{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T23:03:14Z","timestamp":1706223794585},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1670","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>The Bruton's tyrosine kinase (BTK) inhibitor zanubrutinib (Brukinsa), which was previously approved by the FDA for treatment of mantle cell lymphoma, Waldenstr\u00f6m's macroglobulinemia, and relapsed or refractory marginal zone lymphoma, has now been approved for treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adults. The BTK inhibitors ibrutinib (Imbruvica) and acalabrutinib (Calquence) were approved earlier for treatment of CLL and SLL.<\/jats:p>","DOI":"10.58347\/tml.2023.1670e","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T16:03:06Z","timestamp":1678982586000},"page":"e33-e34","source":"Crossref","is-referenced-by-count":1,"title":["In Brief: Zanubrutinib (Brukinsa) for CLL or SLL"],"prefix":"10.58347","volume":"65","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2023,2,20]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T16:03:06Z","timestamp":1678982586000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1670e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":0,"journal-issue":{"issue":"1670","published-online":{"date-parts":[[2023,2,20]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2023.1670e","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}